跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,102 条关于
“PIM/FLT3”
全部
2,102
临床试验
1,435
药物
391
机构
37
资讯
239
去年
First Patient Dosed in Phase II JASPIS-01 Trial of Dapolsertib for Relapsed/Refractory DLBCL
去年
Ryvu Therapeutics Partners with BioNTech to Accelerate Cancer Immunotherapy Trials in Poland
10个月前
Ryvu Therapeutics Presents Promising Clinical Data on Romaciclib and Dapolsertib at ASH 2025
去年
Ryvu Therapeutics Advances Synthetic Lethality Pipeline with Promising Preclinical Data at AACR 2025
2年前
Ryvu Therapeutics to Present Promising RVU120 and Synthetic Lethality Data at Major Oncology Conferences
去年
Emavusertib Shows Promise in FLT3-Mutated AML Patients Resistant to Prior Therapies
5个月前
Quizartinib Combination Therapy Shows Promise in Phase II Trial for FLT3-ITD AML
去年
Invivoscribe's LeukoStrat CDx FLT3 Mutation Assay Receives Regulatory Approval in UK and Switzerland
6年前
EU Approves Astellas' Xospata for FLT3-Positive AML, Showing Survival Benefit Over Chemotherapy
2年前
Hemogenyx's FLT3 Assay Ready for HEMO-CAR-T Phase I Trials in AML
第 1 页,共 24 页
上一页
下一页